What we're about

Anyone interested in the process of product development and commercialization in the healthcare space. Opportunities to network with like-minded professionals and learn during educational forums on topics of current interest.

Upcoming events (1)

Advances in Diabetes Care

Regis College

Diabetes Clinical Update New insights on both Type 1 Diabetes and Type 2 Diabetes from the perspective of a leading clinical researcher. Dr. Gabbay, the Chief Medical Officer of the Joslin Diabetes Center, will moderate our program, and he will provide an overview of the best clinical practices in diabetes care today, as well as the challenges involved in helping people with diabetes to effectively manage their diabetes. Smart Devices and Wearables How connected health is impacting care, medication and insulin titration and adherence, and clinical and economic outcomes for payers, providers, employers, etc. James White, the co-founder of Common Sensing, a smart insulin pen company, will describe the advances underway in using real time glucose information to help patients and their care teams to optimize diabetes management to drive better clinical and economic outcomes. Artificial Pancreas and AI Closed loop systems, AI and cloud base diabetes decision support tools, and telemedicine/remote monitoring solutions. Dr. Trang Ly, the Chief Medical Officer at Insulet, will discuss how continuous glucose monitor (CGM) systems, with smart AI and closed loop algorithms, will provide patients with a worry free "artificial pancreas" that will mimic a normal pancreas, helping keep people with diabetes in control of their blood glucose levels. Advancements in Encapsulation Creating an environment for new beta cells to thrive, responding to glucose and producing insulin, and being protected from the immune system. Lastly, Dr. Linda Tempelman, CEO, Giner Life Sciences, will discuss how encapsulization devices can provide a nourishing and protected environment utilizing an oxygen delivery technology for use with a fully-implanted Type I Diabetes (T1D) cell therapy treatment employing immune-isolation capsule technology for allogenic pancreatic islets or stem-cell derived pancreatic islet-like cell clusters.

Past events (7)

Pathways to Success for MedTech Startups

155 Seaport Blvd

Photos (21)

Find us also at